1]        Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11).

[2]       Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Vol. 116, Cardiovascular Research. 2020.

[3]       Graham RL, Donaldson EF, Baric RS. A decade after SARS: Strategies for controlling emerging coronaviruses. Vol. 11, Nature Reviews Microbiology. 2013.

[4]       Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4).

[5]      Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;

[6]       Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017;97(1).

[7]       Griffith DM, Sharma G, Holliday CS, Enyia OK, Valliere M, Semlow AR, et al. Men and COVID-19: A biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Vol. 17, Preventing Chronic Disease. 2020.

[8]       Barber SJ, Kim H. COVID-19 Worries and Behavior Changes in Older and Younger Men and Women. Journals Gerontol - Ser B Psychol Sci Soc Sci. 2021;76(2).

[9]       Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Vol. 11, Biology of Sex Differences. 2020.

[10]     Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11(1).

[11]     Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [published correction appears in Lancet Respir Med. 2020 Feb 25;:]. Lancet Respir Med. 2020;8(4):420-422. doi:10.1016/S2213-2600(20)30076-X. Lancet Respir Med. 2020;8(feb 25).

[12]     Xu J, Xiao W, Liang X, Shi L, Zhang P, Wang Y, et al. A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity. BMC Public Health. 2021;21(1).

[13]     ENG A, PANDYA N, PATEL R. COVID-19 AND COXSACKIE B COINFECTION: A RARE CASE OF ACUTE PERICARDITIS. Chest. 2021;160(4).

[14]     Barcena ML, Pozdniakova S, Haritonow N, Breiter P, Kühl AA, Milting H, et al. Dilated cardiomyopathy impairs mitochondrial biogenesis and promotes inflammation in an age- and sex-dependent manner. Aging (Albany NY). 2020;12(23).

[15]     Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8).

[16]    Chen J, Bai H, Liu J, Chen G, Liao Q, Yang J, et al. Distinct Clinical Characteristics and Risk Factors for Mortality in Female Inpatients with Coronavirus Disease 2019 (COVID-19): A Sex-stratified, Large-scale Cohort Study in Wuhan, China. Clin Infect Dis. 2020;71(12).

[17]     Connelly PJ, Azizi Z, Alipour P, Delles C, Pilote L, Raparelli V. The Importance of Gender to Understand Sex Differences in Cardiovascular Disease. Vol. 37, Canadian Journal of Cardiology. 2021.

[18]     Raparelli V, Romiti GF, Spugnardi V, Borgi M, Cangemi R, Basili S, et al. Gender-related determinants of adherence to the mediterranean diet in adults with ischemic heart disease. Nutrients. 2020;12(3).

[19]     Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837).

[20]     Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108.

[21]     Zore T, Palafox M, Reue K. Sex differences in obesity, lipid metabolism, and inflammation—A role for the sex chromosomes? Vol. 15, Molecular Metabolism. 2018.

[22]     Busetto L, Bettini S, Fabris R, Serra R, Dal Pra C, Maffei P, et al. Obesity and COVID-19: An Italian Snapshot. Obesity. 2020;28(9).

[23]    Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States. Diagnosis. 2020;7(2).

[24]     Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yiannikouris F, Zhang X, et al. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol. 2012;32(6).

[25]     Correction to Sex difference and smoking predisposition in patients with COVID-19 (The Lancet Respiratory Medicine (2020) 8(4) (e20), (S221326002030117X), (10.1016/S2213-2600(20)30117-X)). Vol. 8, The Lancet Respiratory Medicine. 2020.

[26]    Maas AHEM, Oertelt-Prigione S. The Coronavirus disease 2019 outbreak highlights the importance of sex-sensitive medicine. Eur Cardiol Rev . 2020;15.

[27]     Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet. 2003;361(9371).

[28]     Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. Vol. 5, JAMA Cardiology. 2020.

[29]     Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Vol. 7, The Lancet Haematology. 2020.

[30]     Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4).

[31]     Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220.

[32]     Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8).

[33]     Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. Vol. 18, Journal of Thrombosis and Haemostasis. 2020.

[34]    Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, et al. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol. 2020;76(18).

[35]     Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Vol. 20, Nature Reviews Immunology. 2020.

[36]    Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Vol. 395, The Lancet. 2020.

[37]    Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA, Stahl M, et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181(4).

[38]     Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Vol. 315, American Journal of Physiology - Heart and Circulatory Physiology. 2018.

[39]     Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59(2).

[40]     Beri A, Kotak K. Cardiac injury, arrhythmia, and sudden death in a COVID-19 patient. Hear Case Reports. 2020;6(7).

[41]     Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7).

[42]    Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China JAMA | Original Investigation | CARING FOR THE CRITICALLY ILL PATIENT. JAMA. 2020;323(11).

[43]    Cho JH, Namazi A, Shelton R, Ramireddy A, Ehdaie A, Shehata M, et al. Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States. Vol. 15, PLoS ONE. 2020.

[44]    Patel VB, Zhong JC, Grant MB, Oudit GY. Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Vol. 118, Circulation Research. 2016.

[45]    Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation. 2010;122(7).

[46]    Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1).

[47]    Fernández-Atucha A, Izagirre A, Fraile-Bermúdez AB, Kortajarena M, Larrinaga G, Martinez-Lage P, et al. Sex differences in the aging pattern of renin-angiotensin system serum peptidases. Biol Sex Differ. 2017;8(1).

[48]    Hudson M, Rahme E, Behlouli H, Sheppard R, Pilote L. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure - A population study. Eur J Heart Fail. 2007;9(6–7).

[49]     Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020;382(25).

[50]     Jehpsson L, Sun J, Nilsson PM, Edsfeldt A, Swärd P. Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin-Converting Enzyme 2 Correlates With Renin and Body Mass Index. Front Physiol. 2021;11.

[51]    Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Vol. 8, The Lancet Diabetes and Endocrinology. 2020.

[52]     Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Vol. 8, Biology of sex differences. 2017.

[53]    Gagliano-Jucá T, Basaria S. Testosterone replacement therapy and cardiovascular risk. Vol. 16, Nature Reviews Cardiology. 2019.

[54]     Snell DM, Turner JMA. Sex Chromosome Effects on Male–Female Differences in Mammals. Vol. 28, Current Biology. 2018.

[55]     Arnold AP, Reue K, Eghbali M, Vilain E, Chen X, Ghahramani N, et al. The importance of having two X chromosomes. Vol. 371, Philosophical Transactions of the Royal Society B: Biological Sciences. 2016.

[56]     Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The Risk of Recurrent Venous Thromboembolism in Men and Women. N Engl J Med. 2004;350(25).

[57]     Lete I. Combined hormonal contraception and COVID-19. Vol. 26, European Journal of Contraception and Reproductive Health Care. 2021.

[58]     Green SJ. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. Vol. 22, Microbes and Infection. 2020.

[59]   Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, et al. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol. 2020;148.